ARYx Therapeutics, Inc. (ARYX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Operating Cash Flow | -34.96 Million | -45.21 Million | -27.7 Million | -4.21 Million | -22.43 Million |
| Net Income | -33.16 Million | -31.21 Million | -27.56 Million | -27.32 Million | -27.96 Million |
| Depreciation & Amortization | 1.08 Million | 1.46 Million | 1.23 Million | 920 Thousand | 982 Thousand |
| Deferred income taxes | 425 Thousand | - | - | - | - |
| Stock-based compensation | 1.93 Million | - | - | - | - |
| Change in working capital | -5.25 Million | -17.74 Million | -2.15 Million | 21.45 Million | 4.13 Million |
| Other non-cash items | 439 Thousand | 2.28 Million | 774 Thousand | 738 Thousand | 421 Thousand |
| Investing Cash Flow | 8.41 Million | -2.41 Million | 23.36 Million | -18.51 Million | 9.52 Million |
| Investments in PPE | -141 Thousand | -644 Thousand | -499 Thousand | -962 Thousand | -3.84 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -11.16 Million | -16.7 Million | -21.2 Million | -69.38 Million | -23.15 Million |
| Sales/Maturities of investments | 19.51 Million | 15.24 Million | 45.22 Million | 51.64 Million | 36.52 Million |
| Other Investing Activities | 200 Thousand | -300 Thousand | -150 Thousand | 190 Thousand | - |
| Financing Cash Flow | -2.03 Million | 28.15 Million | 41.15 Million | 28.93 Million | 11.18 Million |
| Debt repayment | -2.98 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -92 Thousand | - | - | - | - |
| Common Stock Issuance | 1.04 Million | 20.44 Million | 44.04 Million | 30.21 Million | 92 Thousand |
| Other Financing Activities | - | 7.7 Million | -2.89 Million | -1.28 Million | 11.08 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -5.25 Million | -17.74 Million | -2.15 Million | 21.45 Million | - |
| Cash at beginning of period | 35.99 Million | 55.47 Million | 18.66 Million | 12.45 Million | 14.18 Million |
| Cash at end of period | 7.4 Million | 35.99 Million | 55.47 Million | 18.66 Million | 12.45 Million |
| Capital Expenditure | -141 Thousand | -644 Thousand | -499 Thousand | -962 Thousand | -3.84 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -28.59 Million | -19.47 Million | 36.81 Million | 6.2 Million | -1.72 Million |
| Free Cash Flow | -35.1 Million | -45.86 Million | -28.2 Million | -5.17 Million | -26.28 Million |
| Breakdown | 2010 Q3 | 2010 Q2 | 2010 Q1 | 2009 Q4 | 2009 FY | 2009 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.51 Million | -3.63 Million | -6.39 Million | -5.78 Million | -33.16 Million | -8.15 Million |
| Depreciation & Amortization | 206 Thousand | 231 Thousand | 251 Thousand | 261 Thousand | 1.08 Million | 270 Thousand |
| Deferred income taxes | - | - | - | - | 425 Thousand | - |
| Stock-based compensation | 138 Thousand | 162 Thousand | 477 Thousand | 207 Thousand | 1.93 Million | 563 Thousand |
| Change in working capital | -1.94 Million | -325 Thousand | -799 Thousand | -858 Thousand | -5.25 Million | 401 Thousand |
| Other non-cash items | 71 Thousand | 53 Thousand | 38 Thousand | 92 Thousand | 439 Thousand | 125 Thousand |
| Investing Cash Flow | 273 Thousand | 204 Thousand | 370 Thousand | 7.26 Million | 8.41 Million | 3.08 Million |
| Investments in PPE | -8000.00 | - | - | -44 Thousand | -141 Thousand | -8000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -11.16 Million | -1.32 Million |
| Sales/Maturities of investments | 281 Thousand | 204 Thousand | 370 Thousand | 7.3 Million | 19.51 Million | 4.2 Million |
| Other Investing Activities | - | - | - | - | 200 Thousand | 200 Thousand |
| Financing Cash Flow | 5.32 Million | -1.58 Million | 4.94 Million | -616 Thousand | -2.03 Million | -1.37 Million |
| Debt repayment | -990 Thousand | -1.52 Million | -1.48 Million | -1.46 Million | -2.98 Million | -1.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -92 Thousand | - |
| Common Stock Issuance | 22 Thousand | -55 Thousand | 6.42 Million | - | 1.04 Million | - |
| Other Financing Activities | 6.29 Million | - | 1000.00 | 850 Thousand | - | 48 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -5.25 Million | - |
| Cash at beginning of period | 1.4 Million | 6.29 Million | 7.4 Million | 6.84 Million | 35.99 Million | 11.93 Million |
| Cash at end of period | 2.95 Million | 1.4 Million | 6.29 Million | 7.4 Million | 7.4 Million | 6.84 Million |
| Capital Expenditure | -8000.00 | - | - | -44 Thousand | -141 Thousand | -8000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.55 Million | -4.89 Million | -1.11 Million | 564 Thousand | -28.59 Million | -5.08 Million |
| Free Cash Flow | -4.05 Million | -3.51 Million | -6.42 Million | -6.12 Million | -35.1 Million | -6.79 Million |
WOSSF
600679
AREC
0QLD
GNMSF
QNBFB